286
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China

, , , , , ORCID Icon, , , , & show all
Pages 6639-6645 | Published online: 12 Oct 2021

Figures & data

Table 1 Characteristics of Overall Chinese Adults and Chinese Adults with Diabetes According to the 2017 CDS Guideline and the 2020 CDS Guideline but Not the 2017 CDS Guideline

Figure 1 Percentage of Chinese adults who had diabetes (left panel), who were recommended to initiate antidiabetic medication among those not taking antidiabetic medication (middle panel), and who with above goal HbA1c among those taking antidiabetic medication (right panel). Data used for estimating were from CHARLS 2011–2012 baseline survey.

Abbreviation: HbA1c, hemoglobin A1c.
Figure 1 Percentage of Chinese adults who had diabetes (left panel), who were recommended to initiate antidiabetic medication among those not taking antidiabetic medication (middle panel), and who with above goal HbA1c among those taking antidiabetic medication (right panel). Data used for estimating were from CHARLS 2011–2012 baseline survey.

Figure 2 Number of Chinese adults who had diabetes (left bar), who were recommended to initiate antidiabetic medication (middle bar), and who with above goal HbA1c (right bar). Data used for estimating were from CHARLS 2011–2012 baseline survey.

Abbreviation: HbA1c, hemoglobin A1c.
Figure 2 Number of Chinese adults who had diabetes (left bar), who were recommended to initiate antidiabetic medication (middle bar), and who with above goal HbA1c (right bar). Data used for estimating were from CHARLS 2011–2012 baseline survey.